ABL domain kinase point mutations as a cause of resistance to therapy of patients with chronic myeloid leukemia with tyrosine kinase inhibitors. Single center experience
Sacha, Tomasz, Foryciarz, Kajetana, Florek, Izabela, Zawada, Magdalena, Czekalska, Sylwia, Cwynar, Dorota, Pecek, Elzbieta, Skotnicki, Aleksander B
Published in Przeglad lekarski (2011)
Get more information
Published in Przeglad lekarski (2011)
Journal Article
Implementation of direct sequencing as a method of ABL gene mutations analysis in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor
Florek, Izabela, Sacha, Tomasz, Zawada, Magdalena, Czekalska, Sylwia, Foryciarz, Kajetana, Cwynar, Dorota, Pecek, Elzbieta, Skotnicki, Aleksander B
Published in Przeglad lekarski (2010)
Get more information
Published in Przeglad lekarski (2010)
Journal Article